
Lupus patients in England in remission after pioneering NHS trial of GM therapy
Five lupus patients in England achieved remission using CAR T-cell therapy, which genetically modifies their own immune cells. This breakthrough treatment could offer a potential cure for the chronic autoimmune disease.
Why good news?
Patients achieving remission represents a concrete medical breakthrough for autoimmune diseases. Using a patient's own modified cells to reset their immune system demonstrates significant scientific progress.
Why it matters?
Lupus and similar autoimmune diseases significantly impact quality of life. Success with this therapy could offer hope to millions of autoimmune disease patients worldwide.




























